Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

BROCK MEDICAL, LLC

NPI: 1023379815 · LONDON, KY 40741 · Nurse Practitioner · NPI assigned 06/07/2012

$63.70M
Total Medicaid Paid
1,656,561
Total Claims
1,387,793
Beneficiaries
54
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialDEANE, ANDREW (VP FINANCE)
NPI Enumeration Date06/07/2012

Related Entities

Other providers sharing the same authorized official: DEANE, ANDREW

ProviderCityStateTotal Paid
FC INDIANA, LLC BEDFORD IN $7.22M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 184,342 $7.05M
2019 220,208 $8.58M
2020 231,084 $9.33M
2021 272,145 $11.79M
2022 269,509 $11.08M
2023 289,635 $9.53M
2024 189,638 $6.34M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
S9083 Global fee urgent care centers 333,029 299,717 $34.46M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 186,893 169,505 $8.68M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 168,379 154,111 $6.86M
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 244,872 222,087 $4.78M
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 62,474 56,116 $3.23M
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 266,052 129,337 $1.46M
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 18,509 16,935 $1.26M
87428 34,558 31,786 $1.23M
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 165,992 152,424 $848K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 41,848 37,880 $275K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 6,960 5,668 $257K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 9,254 6,891 $108K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2,384 2,021 $76K
J0696 Injection, ceftriaxone sodium, per 250 mg 4,527 4,082 $54K
96127 19,190 16,987 $39K
87807 5,574 5,087 $23K
71046 Radiologic examination, chest; 2 views 2,452 2,281 $17K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 22,120 19,355 $9K
81003 26,633 24,391 $8K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 277 264 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 772 726 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg 3,231 2,880 $2K
99406 540 454 $2K
99215 Prolong outpt/office vis 15 14 $1K
99205 Prolong outpt/office vis 14 13 $1K
90756 100 99 $1K
90674 113 107 $1K
99051 4,833 4,183 $1K
74018 83 83 $742.03
86308 172 162 $449.24
J1040 Injection, methylprednisolone acetate, 80 mg 53 52 $372.26
82962 217 195 $226.41
81025 210 191 $190.29
73610 12 12 $168.86
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 77 57 $156.48
36415 Collection of venous blood by venipuncture 63 52 $143.34
73630 36 36 $135.59
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 25 24 $67.72
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 328 312 $10.73
A6448 Light compression bandage, elastic, knitted/woven, width less than three inches, per yard 41 40 $8.29
99000 970 736 $7.43
J7510 Prednisolone oral, per 5 mg 13 13 $4.95
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 42 37 $2.79
J8540 Dexamethasone, oral, 0.25 mg 19 19 $2.75
3725F 9,201 8,098 $0.00
888888 5,414 5,185 $0.00
4004F 178 156 $0.00
3351F 6,751 5,952 $0.00
3352F 451 414 $0.00
3353F 280 260 $0.00
4000F 178 156 $0.00
96373 82 82 $0.00
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 13 13 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 57 55 $0.00